BioSig Technologies (BSGM) announces that its common stock will continue trading on The Nasdaq Capital Market. On March 24, 2025, the Company received formal notice from The Nasdaq Stock Market LLC confirming that it has met the required minimum stockholders’ equity threshold of $2.5M as outlined in Listing Rule 5550. As a result, the Company’s previously disclosed deficiency has been resolved, and the Company now remains in full compliance with all applicable Nasdaq continued listing standards.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.